"In light of the Company’s inability to presently predict the duration of the stop ship, the Company believes that it will be ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study ...

A study published in the American Journal of Roentgenology demonstrated the powerful potential of AI-powered mammography, ...

Momentum is driven by the declining cost of capital and strong operating fundamentals,' the Blackstone executive told PE Hub.

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Marlborough medical device manufacturer Hologic is anticipating to make an unspecified number of layoffs at international locations this year amid a restructuring of its diagnostics division, as sales ...

Hologic stock (NASDAQ: HOLX) has rallied around 83% over recent weeks (vs. about a 40% gain in the S&P 500) to its current level of $53 after falling to a low of $29 in late March as a rapid increase ...